Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Corcept Therapeutics (CORT)

$14.05 0.05 (0.35%)

16:07 EDT CORT Stock Quote Delayed 15 Minutes

Volume:

Previous Close $14.10

Market Cap 1.62B

PE Ratio 12.32

EPS 1.14

Volume (Avg. Vol.) 510,247

Day's Range 13.81 - 14.12

52-Week Range 9.14 - 19.48

Dividend & Yield N/A (N/A)

CORT Stock Predictions, Articles, and Corcept Therapeutics News

From InvestorPlace
From the Web

FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs

By Karl Utermohlen, InvestorPlace Writer May 18, 2018

The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are.

10 Healthcare Stocks to Stave Off the Market Flu

By Louis Navellier, Editor, Growth Investor Apr 6, 2018

One thing is certain, healthcare isn’t going away.

Plains GP Holdings LP (PAGP) and Green Plains Inc (GPRE) Lead Today’s Top 11 Investor Filings

By Fintel Jun 15, 2017

13D and 13G filings are windows on activist investor activity. Today we focus on Plains GP Holdings LP, Green Plains Inc and 9 other filings

7 Healthcare Stocks With A-Rated Prospects

By Louis Navellier, Editor, Growth Investor Apr 21, 2017

An Obamacare replacement is back in the news, and these seven A-rated healthcare stocks are winners regardless of how it shakes out.

Why Corcept (CORT) is Poised to Beat Earnings Estimates Again

From Zacks Investment Research Oct 14, 2019

Corcept (CORT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Benzinga's Top Upgrades, Downgrades For September 24, 2019

From Benzinga Sep 24, 2019

Upgrades For Bank of Nova Scotia (NYSE: BNS), Bank of America upgraded the stock from Neutral to Buy. In the third quarter, Bank of Nova Scotia showed an EPS of $1.43, compared...

Evercore likes 10x Genomics in premarket analyst action

From Seeking Alpha Sep 24, 2019

10x Genomics (NASDAQ:TXG) initiated with Outperform rating and $70 (16% upside) price target at Evercore ISI.Aurora Cannabis (NYSE:ACB) initiated with Neutral rating and C$7 (4% upside) price target a

Amgen Stock Is The Biggest Biotech Stock, But Should You Buy It?

From Investor's Business Daily Sep 13, 2019

Amgen stock is on an upswing after winning a patent battle over its drug Enbrel. Is it time to buy shares of the biotech company?

Benzinga's Top Upgrades, Downgrades For September 6, 2019

From Benzinga Sep 6, 2019

Upgrades For AGCO Corp (NYSE: AGCO), Stifel Nicolaus upgraded the stock from Hold to Buy. AGCO earned $1.82 in the second quarter, compared to $1.32 in the year-ago quarter. The...

Cantor likes Durect in premarket analyst action

From Seeking Alpha Sep 6, 2019

Durect (NASDAQ:DRRX) initiated with Overweight rating and $5 (201% upside) price target at Cantor Fitzgerald.Ekso Bionics Holdings (NASDAQ:EKSO) initiated with Overweight rating and $1 (79% upside) pr

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!